Palvella Therapeutics (PVLA) Receivables (2016 - 2024)
Historic Receivables for Palvella Therapeutics (PVLA) over the last 11 years, with Q3 2024 value amounting to $879000.0.
- Palvella Therapeutics' Receivables fell 1588.52% to $879000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $879000.0, marking a year-over-year decrease of 1588.52%. This contributed to the annual value of $3.1 million for FY2023, which is 7031.47% down from last year.
- Latest data reveals that Palvella Therapeutics reported Receivables of $879000.0 as of Q3 2024, which was down 1588.52% from $4.5 million recorded in Q2 2024.
- In the past 5 years, Palvella Therapeutics' Receivables registered a high of $17.0 million during Q2 2021, and its lowest value of $829000.0 during Q3 2022.
- Moreover, its 5-year median value for Receivables was $3.1 million (2023), whereas its average is $5.1 million.
- As far as peak fluctuations go, Palvella Therapeutics' Receivables tumbled by 9256.47% in 2022, and later skyrocketed by 37626.05% in 2024.
- Over the past 5 years, Palvella Therapeutics' Receivables (Quarter) stood at $1.7 million in 2020, then skyrocketed by 94.2% to $3.3 million in 2021, then soared by 219.38% to $10.6 million in 2022, then plummeted by 70.31% to $3.1 million in 2023, then crashed by 72.02% to $879000.0 in 2024.
- Its Receivables was $879000.0 in Q3 2024, compared to $4.5 million in Q2 2024 and $4.9 million in Q1 2024.